日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Combination of the MTA-Cooperative PRMT5 Inhibitor BMS-986504 and KRAS Inhibitors Is an Effective Treatment Strategy for MTAP-Deleted KRAS-Mutant Pancreatic Cancer

MTA 协同 PRMT5 抑制剂 BMS-986504 与 KRAS 抑制剂联合使用是治疗 MTAP 缺失 KRAS 突变型胰腺癌的有效策略

Drizyte-Miller, Kristina; Engstrom, Lars D; Klomp, Jeffrey A; Stalnecker, Clint A; Stamey, Addison G; Taylor, Khalilah E; Roach, Mallory K; Robb, Ryan; Waters, Laura M; Calinisan, Andrew; Degan, Seamus; Chang, Wen-Hsuan; Helu, Xousaen M; Nguyen, David; Baldelli, Elisa; Pierobon, Mariaelena; Petricoin, Emanuel F; Briere, David M; Hallin, Jill; Christensen, James G; Bryant, Kirsten L; Cox, Adrienne D; Olson, Peter; Der, Channing J

Concurrent Inhibition of the RAS-MAPK Pathway and PIKfyve Is a Therapeutic Strategy for Pancreatic Cancer.

同时抑制 RAS-MAPK 通路和 PIKfyve 是胰腺癌的一种治疗策略

DeLiberty Jonathan M, Roach Mallory K, Stalnecker Clint A, Robb Ryan, Schechter Elyse G, Pieper Noah L, Taylor Khalilah E, Pita Lily M, Yang Runying, Bang Scott, Drizyte-Miller Kristina, Ackermann Sarah E, Nicewarner Peña Sheila R, Baldelli Elisa, Min Sophia M, Drewry David H, Petricoin Emanuel F 3rd, Morris John P 4th, Der Channing J, Cox Adrienne D, Bryant Kirsten L

KRAS: the Achilles' heel of pancreas cancer biology

KRAS:胰腺癌生物学的阿喀琉斯之踵

Drizyte-Miller, Kristina; Talabi, Taiwo; Somasundaram, Ashwin; Cox, Adrienne D; Der, Channing J

Rab32 regulates Golgi structure and cell migration through Protein Kinase A-mediated phosphorylation of Optineurin.

Rab32 通过蛋白激酶 A 介导的 Optineurin 磷酸化来调节高尔基体结构和细胞迁移

Johnson Katherine M, Marley Maxwell G, Drizyte-Miller Kristina, Chen Jing, Cao Hong, Mostafa Nourhan, Schott Micah B, McNiven Mark A, Razidlo Gina L

Dordaviprone/ONC201 Activation of the ClpP Mitochondrial Protease Inhibits the Growth of KRAS-Mutant Pancreatic Cancer and Overcomes RAS Inhibitor Resistance

多达维普隆/ONC201激活ClpP线粒体蛋白酶,抑制KRAS突变型胰腺癌的生长并克服RAS抑制剂耐药性。

Drizyte-Miller, Kristina; Degan, Seamus E; Mouery, Ryan D; Amparo, Amber M; Mouery, Brandon L; Chang, Wen-Hsuan; Yang, Runying; Nicewarner Peña, Sheila R; Baldelli, Elisa; Klomp, Jeffrey A; Iwanowicz, Edwin J; Graves, Lee M; Petricoin, Emanuel F; Cox, Adrienne D; Stalnecker, Clint A; Bryant, Kirsten L; Der, Channing J

Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer

RAS-GTP 抑制对胰腺癌的肿瘤选择性活性

Urszula N Wasko #, Jingjing Jiang #, Tanner C Dalton, Alvaro Curiel-Garcia, A Cole Edwards, Yingyun Wang, Bianca Lee, Margo Orlen, Sha Tian, Clint A Stalnecker, Kristina Drizyte-Miller, Marie Menard, Julien Dilly, Stephen A Sastra, Carmine F Palermo, Marie C Hasselluhn, Amanda R Decker-Farrell, Step

Author Correction: Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer

作者更正:RAS-GTP抑制剂在胰腺癌中的肿瘤选择性活性

Wasko, Urszula N; Jiang, Jingjing; Dalton, Tanner C; Curiel-Garcia, Alvaro; Edwards, A Cole; Wang, Yingyun; Lee, Bianca; Orlen, Margo; Tian, Sha; Stalnecker, Clint A; Drizyte-Miller, Kristina; Menard, Marie; Dilly, Julien; Sastra, Stephen A; Palermo, Carmine F; Hasselluhn, Marie C; Decker-Farrell, Amanda R; Chang, Stephanie; Jiang, Lingyan; Wei, Xing; Yang, Yu C; Helland, Ciara; Courtney, Haley; Gindin, Yevgeniy; Muonio, Karl; Zhao, Ruiping; Kemp, Samantha B; Clendenin, Cynthia; Sor, Rina; Vostrejs, William P; Hibshman, Priya S; Amparo, Amber M; Hennessey, Connor; Rees, Matthew G; Ronan, Melissa M; Roth, Jennifer A; Brodbeck, Jens; Tomassoni, Lorenzo; Bakir, Basil; Socci, Nicholas D; Herring, Laura E; Barker, Natalie K; Wang, Junning; Cleary, James M; Wolpin, Brian M; Chabot, John A; Kluger, Michael D; Manji, Gulam A; Tsai, Kenneth Y; Sekulic, Miroslav; Lagana, Stephen M; Califano, Andrea; Quintana, Elsa; Wang, Zhengping; Smith, Jacqueline A M; Holderfield, Matthew; Wildes, David; Lowe, Scott W; Badgley, Michael A; Aguirre, Andrew J; Vonderheide, Robert H; Stanger, Ben Z; Baslan, Timour; Der, Channing J; Singh, Mallika; Olive, Kenneth P

Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers

定义 KRAS 突变癌症中的 KRAS 和 ERK 依赖性转录组

Jeffrey A Klomp, Jennifer E Klomp, Clint A Stalnecker, Kirsten L Bryant, A Cole Edwards, Kristina Drizyte-Miller, Priya S Hibshman, J Nathaniel Diehl, Ye S Lee, Alexis J Morales, Khalilah E Taylor, Sen Peng, Nhan L Tran, Laura E Herring, Alex W Prevatte, Natalie K Barker, Laura D Hover, Jill Hallin,

Determining the ERK-regulated phosphoproteome driving KRAS-mutant cancer

确定驱动 KRAS 突变癌症的 ERK 调节磷酸化蛋白质组

Jennifer E Klomp, J Nathaniel Diehl, Jeffrey A Klomp, A Cole Edwards, Runying Yang, Alexis J Morales, Khalilah E Taylor, Kristina Drizyte-Miller, Kirsten L Bryant, Antje Schaefer, Jared L Johnson, Emily M Huntsman, Tomer M Yaron, Mariaelena Pierobon, Elisa Baldelli, Alex W Prevatte, Natalie K Barker

Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer

与 CDK4/6 抑制剂联合治疗 KRAS 突变型胰腺癌

Craig M Goodwin, Andrew M Waters, Jennifer E Klomp, Sehrish Javaid, Kirsten L Bryant, Clint A Stalnecker, Kristina Drizyte-Miller, Bjoern Papke, Runying Yang, Amber M Amparo, Irem Ozkan-Dagliyan, Elisa Baldelli, Valerie Calvert, Mariaelena Pierobon, Jessica A Sorrentino, Andrew P Beelen, Natalie Bub